Decision for funding in the neurology, immunosuppressants, diabetes and antithrombotic therapy areas
We’re pleased to announce the approval of a decision relating to medicines in the neurology, immunosuppressant, diabetes and antithrombotic areas.
Proposals for funding in the immunosuppressant, oncology, vasodilator and smoking cessation therapeutic areas
We are seeking feedback on proposals for funding in the immunosuppressant, oncology, vasodilator and smoking cessation therapeutic areas.
Closes: 5pm Friday, 26 July 2019.
PHARMAC and Ngā Pou Mana (NPM) are calling for scholarship award nominations for Māori kaimahi, students and community members who have had a positive impact on whānau, hapū and iwi.
Request dated 24 May 2019 under the Official Information Act 1982 (OIA) for information relating to communications between Keith Petrie, Kate MacKrill and PHARMAC since August 2018.
PHARMAC invites tenders for the supply of labetalol to DHB hospitals and to community pharmacies in New Zealand.
All proposals must be submitted to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 5.00 pm (New Zealand time) on Friday, 26 July 2019 - RFx ID 21214858.
If you have any questions about this RFP, please post these on the Government Electronic Tenders Service (www.gets.govt.nz).
Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested organisations to register with GETS and subscribe to this RFP to be kept up to date.
We’re pleased to announce that from 1 July 2019 funding of the pertussis (whooping cough) vaccine will include pregnant women in the second and third trimester of their pregnancy, as well as parents or primary caregivers of infants admitted to a Neonatal Intensive Care Unit or Specialist Care Baby Unit for more than 3 days.
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2018/19 Invitation to Tender, dated 1 November 2018.
Request received 22 May for information relating to meningococcal vaccine meetings.
Request dated 6 May 2019 for data on etanercept, adalimumab, infliximab and secukinumab.
Request dated 7 May 2019 for information relating to pharmaceutical budget bids.
Request dated 29 April 2019 for information relating to pharmaceutical budget bids.
Request dated 23 May 2019 for information relating to treatment of ulcerative colitis and crohn’s disease.
Request dated 20 May 2019 for information relating to infliximab pack sales.
Request dated 15 May 2019 for information relating to compounded suspensions for epilepsy.
Request dated 13 December 2018 for information relating to Zytiga.
Request dated 10 December 2018 for information relating to etoposide.
Request for information dated 28 November 2018 on the supply of benzathine penicillin G.
Request dated 29 March 2019 for information relating to oxycodone and the use of opioids.
Request dated 2 May 2019 for the minutes of the MSTAC meetings.
Request dated 14 May 2019 for information relating to mesalazine.